These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17520415)

  • 1. Regarding Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol. 2007;86:48-54.
    van Stralen G; van Roosmalen J
    Acta Obstet Gynecol Scand; 2007; 86(6):764; author reply 765. PubMed ID: 17520415
    [No Abstract]   [Full Text] [Related]  

  • 2. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial.
    van Stralen G; Veenhof M; Holleboom C; van Roosmalen J
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):398-403. PubMed ID: 23231499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retained placenta.
    Weeks AD
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1103-17. PubMed ID: 18793876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta.
    Notten F; Meertens L; Wissink B; Scheepers HC
    Arch Gynecol Obstet; 2014 Jan; 289(1):35-40. PubMed ID: 23771186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial.
    Alalaf SK; Al Tawil NG; Jawad AK; Mahmoud MB; Muhamad BQ; Abdul Rahman KH; Sileem SA; Hassan JN; Ameen KM; Mustafa SA; Bawadikji AA
    J Obstet Gynaecol Res; 2020 May; 46(5):727-735. PubMed ID: 32157797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention rates for placental removal following induction abortion with misoprostol.
    Green J; Borgatta L; Sia M; Kapp N; Saia K; Carr-Ellis S; Vragovic O
    Contraception; 2007 Oct; 76(4):310-3. PubMed ID: 17900443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual nitroglycerin seems to be effective in the management of retained placenta.
    Ekerhovd E; Bullarbo M
    Acta Obstet Gynecol Scand; 2008; 87(2):222-5. PubMed ID: 18231892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of retained placenta by misoprostol in second trimester abortion.
    Li YT; Yin CS
    Int J Gynaecol Obstet; 2001 Aug; 74(2):215-6. PubMed ID: 11502305
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there a place for intra-umbilical oxytocin for the management of retained placenta?
    Sivalingam N; Surinder S
    Med J Malaysia; 2001 Dec; 56(4):451-9. PubMed ID: 12014765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial.
    Nassar AH; Abdallah R; Usta IM
    Obstet Gynecol; 2008 Jun; 111(6):1444-5; author reply 1445. PubMed ID: 18515531
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage.
    Adekanmi OA; Purmessur S; Edwards G; Barrington JW
    BJOG; 2001 May; 108(5):541-2. PubMed ID: 11368143
    [No Abstract]   [Full Text] [Related]  

  • 14. Mifepristone and Misoprostol for the management of placenta accreta - a new alternative approach.
    Morgan M; Atalla R
    BJOG; 2009 Jun; 116(7):1002-3. PubMed ID: 19533837
    [No Abstract]   [Full Text] [Related]  

  • 15. Umbilical vein injection of oxytocin for retained placenta.
    Ekele B; Morhason-Bello I
    Lancet; 2010 Jan; 375(9709):98-9. PubMed ID: 20004012
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia.
    Saxena P; Sarda N; Salhan S; Nandan D
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):101-6. PubMed ID: 18275580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial.
    van Beekhuizen HJ; de Groot AN; De Boo T; Burger D; Jansen N; Lotgering FK
    Am J Obstet Gynecol; 2006 Feb; 194(2):446-50. PubMed ID: 16458644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol.
    Batukan C; Ozgun MT; Ozcelik B; Aygen E; Sahin Y; Turkyilmaz C
    Fertil Steril; 2008 Apr; 89(4):966-73. PubMed ID: 17681307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method to determine stability and recovery of carboprost and misoprostol in infusion preparations.
    Chu KO; Wang CC; Pang CP; Rogers MS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):83-91. PubMed ID: 17692579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.
    Sundaram S; Diaz JP; González-Quintero VH; Verma U
    Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.